CYCLERION THERAPEUTICS INC (CYCN) Stock Analyst Ratings
USA - NASDAQ:CYCN - US23255M2044 - Common Stock
1.87 USD
-0.05 (-2.6%)
ChartMill assigns a Buy % Consensus number of 83% to CYCN. The Buy consensus is the weighted average rating of the current analysts ratings.
CYCN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CYCN.
In the previous month the buy percentage consensus was at a similar level.
CYCN was analyzed by 7 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-10-20 | Truist Securities | Initiate | Buy |
| 2021-09-24 | Cantor Fitzgerald | Initiate | Overweight |
CYCLERION THERAPEUTICS INC / CYCN FAQ
What is the consensus rating for CYCLERION THERAPEUTICS INC (CYCN) stock?
The consensus rating for CYCLERION THERAPEUTICS INC (CYCN) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.